Literature DB >> 17603019

The nuclear localization of SOCS6 requires the N-terminal region and negatively regulates Stat3 protein levels.

Mi-Na Hwang1, Chan-Hee Min, Hyung Sik Kim, Ho Lee, Kyong-Ah Yoon, Sung Yong Park, Eun Sook Lee, Sungpil Yoon.   

Abstract

We determined that endogenous- and overexpressed- SOCS6 was localized in both the nucleus and cytoplasm. The localization of SOCS6 depended on amino acids 1-210 in the N-terminal region of the protein, which contains an unidentified domain. GFP-tagged SOCS6 or the N-terminal region, was exclusively localized and widely distributed throughout the entire nucleus, whereas the C-terminal region displayed a nuclear omission pattern. We also demonstrated that the SOCS6 protein could decrease the levels of the Stat3 protein in the nucleus, and that its negative regulation of the Stat3 protein level was dependent on its C-terminal region. These observations suggest that SOCS6 is composed of at least two functional domains required for its biological role in localizing and degrading Stat3 in the nucleus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17603019     DOI: 10.1016/j.bbrc.2007.06.062

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  SOCS5 and SOCS6 have similar expression patterns in normal and cancer tissues.

Authors:  Sungpil Yoon; Young-Su Yi; Sang Soo Kim; Ju-Hwa Kim; Won Sang Park; Suk Woo Nam
Journal:  Tumour Biol       Date:  2011-11-12

2.  Structural basis for c-KIT inhibition by the suppressor of cytokine signaling 6 (SOCS6) ubiquitin ligase.

Authors:  Fahad Zadjali; Ashley C W Pike; Mattias Vesterlund; Jianmin Sun; Chenggang Wu; Shawn S C Li; Lars Rönnstrand; Stefan Knapp; Alex N Bullock; Amilcar Flores-Morales
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

3.  MicroRNA-424-5p suppresses the expression of SOCS6 in pancreatic cancer.

Authors:  Kemin Wu; Guohuang Hu; Xin He; Peng Zhou; Jian Li; Bin He; Weijia Sun
Journal:  Pathol Oncol Res       Date:  2013-05-09       Impact factor: 3.201

4.  SOCS proteins in development and disease.

Authors:  Monique C Trengove; Alister C Ward
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

5.  MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer.

Authors:  Rong Shen; Yu Wang; Cai-Xia Wang; Miao Yin; Hong-Liang Liu; Jian-Peng Chen; Jun-Qing Han; Wei-Bo Wang
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

6.  Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma.

Authors:  Can Küçük; Xiaozhou Hu; Bei Jiang; David Klinkebiel; Huimin Geng; Qiang Gong; Alyssa Bouska; Javeed Iqbal; Philippe Gaulard; Timothy W McKeithan; Wing C Chan
Journal:  Clin Cancer Res       Date:  2015-01-22       Impact factor: 12.531

7.  Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis.

Authors:  Xinyu Qiu; Jianyong Zheng; Xiaodong Guo; Xingchun Gao; Hui Liu; Yanyang Tu; Yongsheng Zhang
Journal:  Mol Cell Biochem       Date:  2013-03-11       Impact factor: 3.396

Review 8.  SOCS6 is a selective suppressor of receptor tyrosine kinase signaling.

Authors:  Nuzhat N Kabir; Jianmin Sun; Lars Rönnstrand; Julhash U Kazi
Journal:  Tumour Biol       Date:  2014-08-30

Review 9.  Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function.

Authors:  Douglas C Palmer; Nicholas P Restifo
Journal:  Trends Immunol       Date:  2009-10-30       Impact factor: 16.687

10.  Expression of SOCSs in human prostate cancer and their association in prognosis.

Authors:  Jian-guo Zhu; Qi-shan Dai; Zhao-dong Han; Hui-chan He; Ru-jun Mo; Guo Chen; Yan-fei Chen; Yong-ding Wu; Sheng-bang Yang; Fu-neng Jiang; Wei-hong Chen; Zhao-lin Sun; Wei-de Zhong
Journal:  Mol Cell Biochem       Date:  2013-05-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.